title: Managing public payment for high-cost, high-benefit treatment: enzyme replacement therapy for Gaucher's disease in Ontario.
authors.affiliation: Department of Pediatrics, Hospital for Sick Children, Department of Health Administration, University of Toronto, Toronto, Ont. jtrc@sickkids.on.ca
authors.forename: J T
authors.initials: JT
authors.lastname: Clarke
authors.forename: D
authors.initials: D
authors.lastname: Amato
authors.forename: R B
authors.initials: RB
authors.lastname: Deber
mesh_terms: D003362:Cost-Benefit Analysis; D016527:Drug Costs; D005776:Gaucher Disease / Q000188:drug therapy*; D005962:Glucosylceramidase / Q000191:economics* / Q000627:therapeutic use*; D006291:Health Policy; D006801:Humans; D009864:Ontario; D012051:Reimbursement Mechanisms
chemical_list: D005962:Glucosylceramidase